Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pooja Mehra, M.D.

Concepts (25)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Clinical Trials, Phase I as Topic120203230.170 Why?
Vincristine1201810500.140 Why?
Lymphoma, Follicular120184460.120 Why?
Prednisone1201815850.120 Why?
Cyclophosphamide1201822520.110 Why?
Research Design1202061180.060 Why?
Antineoplastic Combined Chemotherapy Protocols12018116260.040 Why?
Doxorubicin1201822420.030 Why?
Neoplasms12020219760.020 Why?
Dose-Response Relationship, Drug12020109140.020 Why?
Disease-Free Survival1201869200.020 Why?
Carcinoma, Renal Cell1202031640.020 Why?
Survival Rate12018128020.020 Why?
Kidney Neoplasms1202042800.010 Why?
Melanoma1202055470.010 Why?
Carcinoma, Non-Small-Cell Lung1202052840.010 Why?
Lung Neoplasms12020132630.010 Why?
Aged, 80 and over12018583610.010 Why?
Retrospective Studies12018787580.010 Why?
Aged120181656290.000 Why?
Humans220207527410.000 Why?
Middle Aged120182160540.000 Why?
Adult120182166580.000 Why?
Male120183543110.000 Why?
Female120183850900.000 Why?
Mehra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (25)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.